Dr Christian Nsanzabana is a biologist by training, and has more than 15 years’ experience in malaria research going from basic to translational and implementation research. He completed his PhD in Molecular Epidemiology at the University of Neuchâtel in 2008, followed by one year at the Centre Suisse de Recherches Scientifiques en Côte d’Ivoire (CSRS), overseeing different projects assessing the efficacy of new products for malaria vector control. Between 2010 and 2015, he was a postdoctoral fellow at the University of California San Francisco (UCSF), and University of Oxford, where he worked on mode of actions and mechanisms of resistance of antimalarial drugs, and meta-analyses to assess the factors affecting efficacy drugs, respectively. He further worked with the Foundation for Innovative New Diagnostics (FIND) on the quality control of malaria rapid diagnostic test. He is currently a Group Leader at Swiss TPH, where he leads the Malaria Genotyping Group.